Table 3.
Clinical characteristics of adults hospitalized with community-acquired pneumonia included in retrospective medical chart review, by age group, Ulaanbaatar, Mongolia, January 2015– February 2019.
| All pneumonia admissions N = 4290 | 18–25 years N = 465 | 26–45 years N = 1471 | 46–65 years N = 1423 | >65 years N = 931 | |
|---|---|---|---|---|---|
| Severe clinical pneumonia, n (%) | 430 (10.0) | 14 (3.0) | 99 (6.7) | 156 (11.0) | 161 (17.3) |
| Patient admitted to ICUa, n (%) | 315 (7.3) | 5 (1.1) | 68 (4.6) | 115 (8.1) | 127 (13.6) |
| Duration of ICUa stay (days), median (IQR) | 2 (1–4) | 2.5 (1.5–3) | 2 (1-4) | 2 (1–3) | 3 (2-4) |
| Oxygen therapy provided, n (%) | 505/4284 (11.8) | 11 (2.4) | 96/1469 (6.5) | 199/1421 (14.0) | 199/929 (21.4) |
| Duration of oxygen therapy (days), median (IQR) | 2 (1–3) | 1 (1–2) | 2 (1–3) | 2 (1–2) | 2 (1–3) |
| Chest drain inserted, n (%) | 18/4289 (0.4) | 1/464 (0.2) | 8 (0.5) | 4 (0.3) | 5 (0.5) |
| Duration of chest drain (days), median (IQR) | 3 (2–3) | 2 (2–2) | 3 (2–4) | 1.5 (1–2) | 3 (3–4) |
| Vasopressor therapy given, n (%) | 101 (2.4) | 1 (0.2) | 22 (1.5) | 45 (3.2) | 33 (3.5) |
| Duration of vasopressor therapy (days), median (IQR) | 2 (1–3) | 1 (1–1) | 1 (1–2) | 3 (1–3) | 3 (1–4.5) |
| Antibiotics given in hospital, n (%) | 4283/4288 (99.9) | 465 (100) | 1468/1470 (99.9) | 1420/1422 (99.9) | 930 (99.9) |
| Duration of antibiotic therapy (days), median (IQR) | 5 (5–6) | 5 (5–6) | 5 (5–6) | 5 (5–6) | 5 (5–6) |
| Length of hospital stay (days), median (IQR) | 7 (7–9) | 7 (7–9) | 7 (7–9) | 7 (7–9) | 8 (7–9) |
| Disease outcome, n (%) | N=4279 | N=464 | N=1470 | N=1419 | N=926 |
| Recovered without sequelae | 1847 (43.2) | 285 (61.4) | 834 (56.7) | 566 (39.9) | 162 (17.5) |
| Recovered with sequelaeb | 2311 (54.0) | 173 (37.3) | 600 (40.8) | 813 (57.3) | 725 (78.3) |
| Death | 46 (1.1) | 0 (0) | 11 (0.8) | 19 (1.3) | 16 (1.7) |
| Transferred to another hospitalc | 75 (1.8) | 6 (1.3) | 25 (1.7) | 21 (1.5) | 23 (2.5) |
IQR = Interquartile range.
a
Intensive care unit.
b
Defined as any pneumonia-related symptoms or any subsequent complications related to their hospitalization at the time of discharge, based on the clinical judgement of treating physicians.
c
Health outcome after transfer not available.